This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruthardt, M.
Right arrow Articles by Pelicci, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruthardt, M.
Right arrow Articles by Pelicci, P. G.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 08 1997, 4859-4869, Vol 17, No. 8
Copyright © 1997, American Society for Microbiology

Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling

M Ruthardt, U Testa, C Nervi, PF Ferrucci, F Grignani, E Puccetti, F Grignani, C Peschle and PG Pelicci
Istituto di Medicina Interna e Scienze Oncologiche, Policlinico Monteluce, Perugia University, Italy.

Fusion proteins involving the retinoic acid receptor alpha (RAR alpha) and the PML or PLZF nuclear protein are the genetic markers of acute promyelocytic leukemias (APLs). APLs with the PML-RAR alpha or the PLZF- RAR alpha fusion protein are phenotypically indistinguishable except that they differ in their sensitivity to retinoic acid (RA)-induced differentiation: PML-RAR alpha blasts are sensitive to RA and patients enter disease remission after RA treatment, while patients with PLZF- RAR alpha do not. We here report that (i) like PML-RAR alpha expression, PLZF-RAR alpha expression blocks terminal differentiation of hematopoietic precursor cell lines (U937 and HL-60) in response to different stimuli (vitamin D3, transforming growth factor beta1, and dimethyl sulfoxide); (ii) PML-RAR alpha, but not PLZF-RAR alpha, increases RA sensitivity of hematopoietic precursor cells and restores RA sensitivity of RA-resistant hematopoietic cells; (iii) PML-RAR alpha and PLZF-RAR alpha have similar RA binding affinities; and (iv) PML-RAR alpha enhances the RA response of RA target genes (those for RAR beta, RAR gamma, and transglutaminase type II [TGase]) in vivo, while PLZF- RAR alpha expression has either no effect (RAR beta) or an inhibitory activity (RAR gamma and type II TGase). These data demonstrate that PML- RAR alpha and PLZF-RAR alpha have similar (inhibitory) effects on RA- independent differentiation and opposite (stimulatory or inhibitory) effects on RA-dependent differentiation and that they behave in vivo as RA-dependent enhancers or inhibitors of RA-responsive genes, respectively. Their different activities on the RA signalling pathway might underlie the different responses of PML-RAR alpha and PLZF-RAR alpha APLs to RA treatment. The PLZF-RAR alpha fusion protein contains an approximately 120-amino-acid N-terminal motif (called the POZ domain), which is also found in a variety of zinc finger proteins and a group of poxvirus proteins and which mediates protein-protein interactions. Deletion of the PLZF POZ domain partially abrogated the inhibitory effect of PLZF-RAR alpha on RA-induced differentiation and on RA-mediated type II TGase up-regulation, suggesting that POZ- mediated protein interactions might be responsible for the inhibitory transcriptional activities of PLZF-RAR alpha.


This article has been cited by other articles:

  • Boukarabila, H., Saurin, A. J., Batsche, E., Mossadegh, N., van Lohuizen, M., Otte, A. P., Pradel, J., Muchardt, C., Sieweke, M., Duprez, E. (2009). The PRC1 Polycomb group complex interacts with PLZF/RARA to mediate leukemic transformation. Genes Dev. 23: 1195-1206 [Abstract] [Full Text]  
  • Gianni', M., Boldetti, A., Guarnaccia, V., Rambaldi, A., Parrella, E., Raska, I. Jr., Rochette-Egly, C., Del Sal, G., Rustighi, A., Terao, M., Garattini, E. (2009). Inhibition of the Peptidyl-Prolyl-Isomerase Pin1 Enhances the Responses of Acute Myeloid Leukemia Cells to Retinoic Acid via Stabilization of RAR{alpha} and PML-RAR{alpha}. Cancer Res. 69: 1016-1026 [Abstract] [Full Text]  
  • van Wageningen, S., Breems-de Ridder, M. C., Nigten, J., Nikoloski, G., Erpelinck-Verschueren, C. A. J., Lowenberg, B., de Witte, T., Tenen, D. G., van der Reijden, B. A., Jansen, J. H. (2008). Gene transactivation without direct DNA binding defines a novel gain-of-function for PML-RAR{alpha}. Blood 111: 1634-1643 [Abstract] [Full Text]  
  • Wichmann, C., Chen, L., Heinrich, M., Baus, D., Pfitzner, E., Zornig, M., Ottmann, O. G., Grez, M. (2007). Targeting the Oligomerization Domain of ETO Interferes with RUNX1/ETO Oncogenic Activity in t(8;21)-Positive Leukemic Cells. Cancer Res. 67: 2280-2289 [Abstract] [Full Text]  
  • Zheng, X., Seshire, A., Ruster, B., Bug, G., Beissert, T., Puccetti, E., Hoelzer, D., Henschler, R., Ruthardt, M. (2007). Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RAR{alpha}-positive leukemic stem cells. haematol 92: 323-331 [Abstract] [Full Text]  
  • Matsushita, H., Scaglioni, P. P., Bhaumik, M., Rego, E. M., Cai, L. F., Majid, S. M., Miyachi, H., Kakizuka, A., Miller, W. H. Jr., Pandolfi, P. P. (2006). In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR{alpha} blockade in the pathogenesis of acute promyelocytic leukemia. JEM 203: 821-828 [Abstract] [Full Text]  
  • Puccetti, E., Zheng, X., Brambilla, D., Seshire, A., Beissert, T., Boehrer, S., Nurnberger, H., Hoelzer, D., Ottmann, O. G., Nervi, C., Ruthardt, M. (2005). The Integrity of the Charged Pocket in the BTB/POZ Domain Is Essential for the Phenotype Induced by the Leukemia-Associated t(11;17) Fusion Protein PLZF/RAR{alpha}. Cancer Res. 65: 6080-6088 [Abstract] [Full Text]  
  • Kumagai, T., Shih, L.-Y., Hughes, S. V., Desmond, J. C., O'Kelly, J., Hewison, M., Koeffler, H. P. (2005). 19-Nor-1,25(OH)2D2 (a Novel, Noncalcemic Vitamin D Analogue), Combined with Arsenic Trioxide, Has Potent Antitumor Activity against Myeloid Leukemia. Cancer Res. 65: 2488-2497 [Abstract] [Full Text]  
  • Nouzova, M., Holtan, N., Oshiro, M. M., Isett, R. B., Munoz-Rodriguez, J. L., List, A. F., Narro, M. L., Miller, S. J., Merchant, N. C., Futscher, B. W. (2004). Epigenomic Changes during Leukemia Cell Differentiation: Analysis of Histone Acetylation and Cytosine Methylation Using CpG Island Microarrays. J. Pharmacol. Exp. Ther. 311: 968-981 [Abstract] [Full Text]  
  • Zheng, X., Beissert, T., Kukoc-Zivojnov, N., Puccetti, E., Altschmied, J., Strolz, C., Boehrer, S., Gul, H., Schneider, O., Ottmann, O. G., Hoelzer, D., Henschler, R., Ruthardt, M. (2004). {gamma}-Catenin contributes to leukemogenesis induced by AML-associated translocation products by increasing the self-renewal of very primitive progenitor cells. Blood 103: 3535-3543 [Abstract] [Full Text]  
  • Muller-Tidow, C., Steffen, B., Cauvet, T., Tickenbrock, L., Ji, P., Diederichs, S., Sargin, B., Kohler, G., Stelljes, M., Puccetti, E., Ruthardt, M., deVos, S., Hiebert, S. W., Koeffler, H. P., Berdel, W. E., Serve, H. (2004). Translocation Products in Acute Myeloid Leukemia Activate the Wnt Signaling Pathway in Hematopoietic Cells. Mol. Cell. Biol. 24: 2890-2904 [Abstract] [Full Text]  
  • Park, D. J., Vuong, P. T., de Vos, S., Douer, D., Koeffler, H. P. (2003). Comparative analysis of genes regulated by PML/RAR{alpha} and PLZF/RAR{alpha} in response to retinoic acid using oligonucleotide arrays. Blood 102: 3727-3736 [Abstract] [Full Text]  
  • Beissert, T., Puccetti, E., Bianchini, A., Guller, S., Boehrer, S., Hoelzer, D., Ottmann, O. G., Nervi, C., Ruthardt, M. (2003). Targeting of the N-terminal coiled coil oligomerization interface of BCR interferes with the transformation potential of BCR-ABL and increases sensitivity to STI571. Blood 102: 2985-2993 [Abstract] [Full Text]  
  • Puccetti, E., Obradovic, D., Beissert, T., Bianchini, A., Washburn, B., Chiaradonna, F., Boehrer, S., Hoelzer, D., Ottmann, O. G., Pelicci, P. G., Nervi, C., Ruthardt, M. (2002). AML-associated Translocation Products Block Vitamin D3-induced Differentiation by Sequestering the Vitamin D3 Receptor. Cancer Res. 62: 7050-7058 [Abstract] [Full Text]  
  • Maurer, A. B., Wichmann, C., Gross, A., Kunkel, H., Heinzel, T., Ruthardt, M., Groner, B., Grez, M. (2002). The Stat5-RARalpha fusion protein represses transcription and differentiation through interaction with a corepressor complex. Blood 99: 2647-2652 [Abstract] [Full Text]  
  • Di Croce, L., Raker, V. A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Coco, F. L., Kouzarides, T., Nervi, C., Minucci, S., Pelicci, P. G. (2002). Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription Factor. Science 295: 1079-1082 [Abstract] [Full Text]  
  • Ward, J. O., McConnell, M. J., Carlile, G. W., Pandolfi, P. P., Licht, J. D., Freedman, L. P. (2001). The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D3-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D3 receptor. Blood 98: 3290-3300 [Abstract] [Full Text]  
  • Sykes, D. B., Kamps, M. P. (2001). Estrogen-dependent E2a/Pbx1 myeloid cell lines exhibit conditional differentiation that can be arrested by other leukemic oncoproteins. Blood 98: 2308-2318 [Abstract] [Full Text]  
  • Hauksdóttir, H., Privalsky, M. L. (2001). DNA Recognition by the Aberrant Retinoic Acid Receptors Implicated in Human Acute Promyelocytic Leukemia. Cell Growth Differ. 12: 85-98 [Abstract] [Full Text]  
  • Zhang, J., Hug, B. A., Huang, E. Y., Chen, C. W., Gelmetti, V., Maccarana, M., Minucci, S., Pelicci, P. G., Lazar, M. A. (2001). Oligomerization of ETO Is Obligatory for Corepressor Interaction. Mol. Cell. Biol. 21: 156-163 [Abstract] [Full Text]  
  • Muller, C., Yang, R., Park, D. J., Serve, H., Berdel, W. E., Koeffler, H. P. (2000). The aberrant fusion proteins PML-RARalpha and PLZF-RARalpha contribute to the overexpression of cyclin A1 in acute promyelocytic leukemia. Blood 96: 3894-3899 [Abstract] [Full Text]  
  • Melnick, A., Carlile, G. W., McConnell, M. J., Polinger, A., Hiebert, S. W., Licht, J. D. (2000). AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein. Blood 96: 3939-3947 [Abstract] [Full Text]  
  • Puccetti, E., Güller, S., Orleth, A., Brüggenolte, N., Hoelzer, D., Ottmann, O. G., Ruthardt, M. (2000). BCR-ABL Mediates Arsenic Trioxide-induced Apoptosis Independently of Its Aberrant Kinase Activity. Cancer Res. 60: 3409-3413 [Abstract] [Full Text]  
  • Redner, R. L., Chen, J. D., Rush, E. A., Li, H., Pollock, S. L. (2000). The t(5;17) acute promyelocytic leukemia fusion protein NPM-RAR interacts with co-repressor and co-activator proteins and exhibits both positive and negative transcriptional properties. Blood 95: 2683-2690 [Abstract] [Full Text]  
  • Kogan, S. C., Hong, S.-h., Shultz, D. B., Privalsky, M. L., Bishop, J. M. (2000). Leukemia initiated by PMLRARalpha : the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable. Blood 95: 1541-1550 [Abstract] [Full Text]  
  • Zhang, T., Xiong, H., Kan, L.-X., Zhang, C.-K., Jiao, X.-F., Fu, G., Zhang, Q.-H., Lu, L., Tong, J.-H., Gu, B.-W., Yu, M., Liu, J.-X., Licht, J., Waxman, S., Zelent, A., Chen, E., Chen, S.-J. (1999). Genomic sequence, structural organization, molecular evolution, and aberrant rearrangement of promyelocytic leukemia zinc finger gene. Proc. Natl. Acad. Sci. USA 96: 11422-11427 [Abstract] [Full Text]  
  • Kukita, A., Kukita, T., Ouchida, M., Maeda, H., Yatsuki, H., Kohashi, O. (1999). Osteoclast-Derived Zinc Finger (OCZF) Protein With POZ Domain, a Possible Transcriptional Repressor, Is Involved in Osteoclastogenesis. Blood 94: 1987-1997 [Abstract] [Full Text]  
  • Naoe, T., Kitamura;, K., Fanelli, M., Pelicci, P. G. (1999). Relationship Between Degradation of PML-RARalpha and Differentiation. Blood 94: 1478-1479 [Full Text]  
  • Du, C., Redner, R. L., Cooke, M. P., Lavau, C. (1999). Overexpression of Wild-Type Retinoic Acid Receptor alpha (RARalpha ) Recapitulates Retinoic Acid-Sensitive Transformation of Primary Myeloid Progenitors by Acute Promyelocytic Leukemia RARalpha -Fusion Genes. Blood 94: 793-802 [Abstract] [Full Text]  
  • Sternsdorf, T., Puccetti, E., Jensen, K., Hoelzer, D., Will, H., Ottmann, O. G., Ruthardt, M. (1999). PIC-1/SUMO-1-Modified PML-Retinoic Acid Receptor alpha  Mediates Arsenic Trioxide-Induced Apoptosis in Acute Promyelocytic Leukemia. Mol. Cell. Biol. 19: 5170-5178 [Abstract] [Full Text]  
  • Coco, F. L., Diverio, D., Falini, B., Biondi, A., Nervi, C., Pelicci, P. G. (1999). Genetic Diagnosis and Molecular Monitoring in the Management of Acute Promyelocytic Leukemia. Blood 94: 12-22 [Full Text]  
  • Melnick, A., Licht, J. D. (1999). Deconstructing a Disease: RAR{alpha}, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia. Blood 93: 3167-3215 [Full Text]  
  • Shaknovich, R., Yeyati, P. L., Ivins, S., Melnick, A., Lempert, C., Waxman, S., Zelent, A., Licht, J. D. (1998). The Promyelocytic Leukemia Zinc Finger Protein Affects Myeloid Cell Growth, Differentiation, and Apoptosis. Mol. Cell. Biol. 18: 5533-5545 [Abstract] [Full Text]  
  • Labrecque, J., Allan, D., Chambon, P., Iscove, N. N., Lohnes, D., Hoang, T. (1998). Impaired Granulocytic Differentiation In Vitro in Hematopoietic Cells Lacking Retinoic Acid Receptors alpha 1 and gamma  . Blood 92: 607-615 [Abstract] [Full Text]  
  • Guidez, F., Ivins, S., Zhu, J., Soderstrom, M., Waxman, S., Zelent, A. (1998). Reduced Retinoic Acid-Sensitivities of Nuclear Receptor Corepressor Binding to PML- and PLZF-RARalpha Underlie Molecular Pathogenesis and Treatment of Acute Promyelocytic Leukemia. Blood 91: 2634-2642 [Abstract] [Full Text]  
  • LIN, R.J., KAO, H.-Y., ORDENTLICH, P., EVANS, R.M. (1998). The Transcriptional Basis of Steroid Physiology. Cold Spring Harb Symp Quant Biol 63: 577-586 [Abstract]